2 papers
physics.soc-ph2026
Mathematical Modeling of HDV RNA, HBV DNA, and HBsAg Dynamics during Lonafarnib-Based Therapy: Insights from the LOWR HDV-1 Study
Adquate Mhlanga, Louis Shekhtman, Rami Zakh +10
Lonafarnib (LNF) is an investigational drug targeting hepatitis delta virus (HDV) but not hepatitis B virus (HBV), providing a unique opportunity to model HDV kinetics and how chan…
physics.soc-ph2026
Modeling hepatitis D virus kinetics during bulevirtide monotherapy: challenges and solutions
Adquate Mhlanga, Louis Shekhtman, Ashish Goyal +11
The entry inhibitor Bulevirtide (BLV) was recently approved in Europe for treatment of chronic hepatitis D virus (HDV) infection, which is considered the most severe viral hepatiti…